Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
May 14, 2024 07:44 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "North America Legal Cannabis Market Report by Products Derived, Distribution Channel, and Country 2024-2032" report has been added to ...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
May 13, 2024 20:22 ET
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
Global Medical Marijuana Strategic Business Report 2024: Market to Reach $82.5 Billion by 2030, U.S. Market is Estimated at $9.9 Billion, While China is Forecast to Grow at 13.6% CAGR
May 13, 2024 09:13 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Medical Marijuana - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Medical Marijuana Market to...
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
May 13, 2024 07:56 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Legal Marijuana - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Legal Marijuana Market to Reach...
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
May 09, 2024 14:51 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
RTI Connext® Named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program
May 09, 2024 10:00 ET
|
Real-Time Innovations (RTI)
RTI Connext® named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program.
Kidney Dialysis Market is expected to reach a revenue of USD 143.8 Bn by 2032, at 6.2% CAGR: Dimension Market Research
May 07, 2024 12:23 ET
|
Dimension Market Research
New York, May 07, 2024 (GLOBE NEWSWIRE) -- Overview The Global Kidney Dialysis Market size reached USD 83.4 billion in 2023 and is further anticipated to reach USD 143.8 billion by 2032 according...
Hemper and Fred Segal Launch Exclusive Smoking Accessory Line
May 07, 2024 09:00 ET
|
HARA Brands
LAS VEGAS, May 07, 2024 (GLOBE NEWSWIRE) -- HARA Brands, a diversified smoking accessory and lifestyle company that designs and sells innovative products for consumers and industry partners,...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024 07:00 ET
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...